🔗 Permalink

Inventor profile of:

James D. McChesney

City:

Etta, Mississippi

Country:

United States

Published Applications:

Last publication date:

2024-09-05

Top Assignees for applications by James D. McChesney

The entities that hold a legal rights for patent applications filed by inventor McChesney James D.:

Tapestry Pharmaceuticals, Inc. 16 Atlanta, GA United States
Arbor Therapeutics, LLC 7 Etta, MS United States
TAPESTRY PHARMACEUTICALS, INC. 6 Boulder, CO United States
Ironstone Separations, Inc. 4 Etta, MS United States
Veiled Therapeutics LLC 4 Etta, MS United States
Arbor Therapeutics, LLC 2 Etta, MI United States
Tapestry Pharmaceuticals, Inc. 1 Altanta, GA United States

Recent patent applications by McChesney James D.

James D. McChesney from Etta, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-05

US20240294540A1

Chemistry; metallurgy

Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration

#2 | 2024-08-15

US20240269108A1

Human necessities

Taxane Analogs for the Treatment of Brain Cancer

#3 | 2023-01-05

US20230000815A1

Human necessities

Acid-Labile Chemotherapeutic Compounds and Compositions

#4 | 2022-03-24

US20220089606A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#5 | 2021-12-30

US20210401797A1

Human necessities

Taxane analogs for the treatment of brain cancer

#6 | 2020-11-05

US20200347076A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#7 | 2020-07-30

US20200237708A1

Human necessities

9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof

#8 | 2020-01-02

US20200002351A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#9 | 2019-05-16

US20190142784A1

Human necessities

9,10-α,α-OH-taxane analogs and methods for production thereof

#10 | 2019-04-25

US20190117784A1

Human necessities

Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents

#11 | 2019-02-14

US20190046501A1

Human necessities

Taxane analogs for the treatment of brain cancer

#12 | 2018-08-23

US20180235883A1

Human necessities

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#13 | 2018-06-14

US20180161439A1

Human necessities

Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents

#14 | 2018-05-10

US20180127344A1

Chemistry; metallurgy

Solubilization of pterostilbene and resveratrol for aqueous beverages

#15 | 2018-05-10

US20180125811A1

Human necessities

9,10-α,α-OH-taxane analogs and methods for production thereof

#16 | 2018-05-03

US20180117002A9

Human necessities

Taxane analogs for the treatment of brain cancer

#17 | 2018-04-19

US20180105535A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#18 | 2017-09-28

US20170273942A1

Human necessities

Taxane Analogs for the Treatment of Brain Cancer

#19 | 2017-02-16

US20170042815A1

Human necessities

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#20 | 2016-12-08

US20160354475A1

Human necessities

Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents

#21 | 2016-11-17

US20160331718A1

Human necessities

9, 10-α, α-oh-taxane analogs and methods for production thereof

#22 | 2016-06-23

US20160176894A1

Chemistry; metallurgy

TAXANE AND ABEO-TAXANE ANALOGS

#23 | 2016-04-28

US20160113898A1

Human necessities

Taxane analogs for the treatment of brain cancer

#24 | 2016-02-25

US20160052850A1

Chemistry; metallurgy

Solubilization of pterostilbene and resveratrol in aqueous beverages

#25 | 2015-07-09

US20150190733A1

Performing operations; transporting

CHROMATOGRAPHY METHODS

#26 | 2015-06-11

US20150158880A1

Chemistry; metallurgy

Taxane and abeo-taxane analogs

#27 | 2015-05-14

US20150133536A1

Human necessities

9,10-α, α-OH-taxane analogs and methods for production thereof

#28 | 2015-03-19

US20150079189A1

Human necessities

Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

#29 | 2014-09-04

US20140249213A1

Human necessities

Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents

#30 | 2014-04-03

US20140093503A1

Chemistry; metallurgy

Taxane and abeo-taxane analogs

#31 | 2014-01-23

US20140023699A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#32 | 2013-11-14

US20130303601A1

Chemistry; metallurgy

Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents

#33 | 2013-09-26

US20130253044A1

Human necessities

Taxane analogs for the treatment of brain cancer

#34 | 2013-08-08

US20130199999A1

Performing operations; transporting

Chromatography methods

#35 | 2013-01-24

US20130022668A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#36 | 2012-12-06

US20120309819A1

Human necessities

Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents

#37 | 2012-03-29

US20120077871A1

Human necessities

9, 10-α, α-OH-taxane analogs and methods for production thereof

#38 | 2011-12-29

US20110318334A1

Human necessities

Taxane analogs for the treatment of brain cancer

#39 | 2011-06-09

US20110135712A1

Chemistry; metallurgy

Biologically active taxane analogs and methods of treatment by oral administration

#40 | 2010-12-23

US20100324128A1

Human necessities

9, 10-α,α-OH-taxane analogs and methods for production thereof

#41 | 2007-08-09

US20070184514A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR DETECTING ACTIVE COMPONENTS USING BIOLUMINESCENT BACTERIA AND THIN-LAYER CHROMATOGRAPHY

InventorID:

52587 ⎘